Trial Details
Not recruitingBasic Information
| Clinical ID | c2520 |
|---|---|
| Identifier | NCT04456517 |
| Trial Title | REACT Trial: A Randomized, Double Blind, Placebo-controlled, Crossover Study of Ranolazine for the Treatment of Crohn's Disease-associated Diarrhea |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Crohn's Disease;Inflammatory Bowel Disease |
| Interventions | Drug: Ranolazine;Drug: Placebo |
Participant Information
| Sponsor | Vanderbilt University Medical Center |
|---|---|
| City | - |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |